Since p130Cas is induced by anti-estrogen therapy [35] and doxorubicin [36] in breast cancer cells, the effects of standard CRC chemotherapy on p130Cas/BCAR1 and EREG expression were investigated in CRC cell lines and metastasis tissues samples. Here, BCAR1 is linked to breast carcinoma.